Prescribing overview
Inhaled glucocorticoid controller with veterinary airway-disease studies in cats, dogs and horses; nasal products are a separate presentation.
A controller anti-inflammatory; it does not rapidly reverse bronchospasm.
Key prescribing checks
- Feline pilot clinical research documented improvement; equine research demonstrated reduced airway hyperresponsiveness.
- Canine deposition and endocrine studies support inhaled exposure research, not a universal efficacy claim.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Cats
Extra-label veterinary evidence; not an animal product approvalAsthma, inhaled
Small randomized pilot trial evaluated naturally occurring disease.
Use / indication source ↗Horses
Extra-label veterinary evidence; not an animal product approvalInflammatory airway disease, inhaled
Trial improved bronchoprovocation measures without significant clinical-score improvement.
Use / indication source ↗Dogs
Extra-label veterinary evidence; not an animal product approvalInhaled deposition/endocrine research
Healthy-dog studies do not establish every clinical indication.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Glucocorticoid anti-inflammatory effects.
Absorption, distribution, metabolism and elimination
CYP3A4 metabolism permits increased systemic exposure with strong inhibitors. Canine lung deposition depends on delivery technique.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Fluticasone Propionate HFA
Human oral-inhalation label; veterinary use is extra-label.
Contraindications · when not to use
- Ingredient hypersensitivity; primary treatment of acute severe asthma.
Precautions & monitoring
- Local fungal infection, adrenal suppression and infection risk require assessment.
Fluticasone Propionate Nasal Spray
Human intranasal label; not an inhaler substitute.
Contraindications · when not to use
- Component hypersensitivity.
Precautions & monitoring
- Nasal bleeding/ulceration, infection and systemic steroid effects require review.
No animal restriction is inferred solely from the human product label.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Human-label concerns include oral fungal infection and systemic adrenal effects; veterinary frequency is not established.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No animal dosing is supplied. The veterinarian must select the exact formulation, delivery device and individual regimen.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Fluticasone Propionate HFA
Human oral-inhalation label; veterinary use is extra-label.
- Strong CYP3A4 inhibitors, including itraconazole, are not recommended by the human label.
Fluticasone Propionate Nasal Spray
Human intranasal label; not an inhaler substitute.
- Strong CYP3A4 inhibitors can increase systemic steroid effects.
Monitoring
Airway control and need for rescue treatment.
Veterinarian review for local infection and steroid-related systemic effects.
Client counseling
Use the exact prescribed inhaler and species-appropriate delivery device.
Nasal spray and combination inhalers are not substitutes; breathing distress needs urgent veterinary care.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow current canister priming, cleaning and storage instructions.
Brands, formulations & ingredient identity
Active ingredients
Fluticasone propionate
Other searchable names: fluticasone propionate HFA · Flovent · Flixotide · Flonase
This record is fluticasone propionate, not fluticasone furoate.
HFA oral-inhalation aerosol and nasal spray use different routes and devices; a nasal spray is not an asthma inhaler.
Brand names and availability vary; verify the active ingredient and current product.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Fluticasone Propionate HFA
- Formulation
- Metered-dose inhalation aerosol
- Label / product scope
- Human product
Human product; veterinary use requires a prescription. Flovent-type single-ingredient controller.
Product label / source ↗Fluticasone Propionate Nasal Spray
- Formulation
- Intranasal metered spray
- Label / product scope
- Human product
Human product; veterinary use requires a prescription. Flonase-type presentation; not interchangeable with HFA.
Product label / source ↗References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
